HTSUY (Hisamitsu Pharmaceutical Co) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HTSUY Hisamitsu Pharmaceutical Co Inc HTSUY
67 GF Score
Price $2.94
GF Value $7.43
Valuation Significantly Undervalued
View Full Analysis

What is Hisamitsu Pharmaceutical Co FFO per Share?

FFO per Share only applies to REITs.

HTSUY
67GF Score
Hisamitsu Pharmaceutical Co Inc HTSUY
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Hisamitsu Pharmaceutical Co (HTSUY) Overvalued in 2026?

Based on GuruFocus' analysis, Hisamitsu Pharmaceutical Co stock appears to be undervalued. The current stock price of $2.94 is trading 60.4% below its estimated GF Value™ of $7.43. GuruFocus considers Hisamitsu Pharmaceutical Co to be Significantly Undervalued.

Key valuation signals for HTSUY:

  • FFO per Share:
  • GF Value™: $7.43 vs. price of $2.94 (60.4% below fair value)
  • GF Score™: 67/100

No single metric tells the full story. See the HTSUY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hisamitsu Pharmaceutical Co Business Description

Address 408 Tashiro Daikancho, Saga Prefecture, Tosu, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is engaged in the research, development, manufacturing, procurement, and sale of pharmaceutical products. The company operates a single business segment, focusing on medical and general pharmaceuticals both in Japan and overseas. It markets drugs under the Salonpas, Nobinobi / Salonsip, Butenalock, and Mohrus brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions, and ointments.
67GF Score

Get the complete analysis for HTSUY

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.94
Price
$7.43
GF Value